Global Biologics Market Size was valued nearly USD 250 billion by 2017 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 10.9% during the forecast period that is 2017-2025. North America is expected to hold the largest share in the global biologics market during the forecast period.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global biologics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global biologics market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

“Biologics are drugs that are prepared from the cells, genes, tissues, recombinant proteins, and other biological components extracted from living organisms which include human, microbes and animals.”

Market Dynamics

The global biologics market is anticipated to grow at a faster pace in the forecast period owing to its rising demand in treatment of a multiple diseases such as cancer, cardio-vascular diseases, hepatitis B and others. The increase in incidence of chronic diseases such as cancer and various metabolic disorders such as diabetes mellitus, Gaucher’s disease, etc. has led to the escalation of several biomedical research activities for the manufacture of biologics, which motivated giant healthcare companies to invest in this market. According to a study, nearly 800 biological molecules are in development phase, which can be further used for the manufacture of biologics. Moreover, initiatives taken by governing bodies of several countries to improve people’s health and provide better medical facilities are resulting in the escalation of regulatory approval of new drugs based on biologics. In the last decade one-third of the total drugs approved were biologics. This will further help the market to grow over the forecast years. The demand for biological drugs over chemically synthesized drugs is also anticipated to generate higher revenue over the coming years, and this will significantly drive the market.

Market Segment

Global biologics market is majorly restrained by the high manufacturing costs, coupled with the complexity in their manufacturing process due to their extra-sensitivity towards environmental factors like heat, light, moisture, etc. The commercialization of non-generic biosimilars will act as an additional restraint to the growth of biologics market over the projected period.

Monoclonal antibodies and their derivatives are of great importance for pharmaceutical companies, as they find a wide-range of applications in the production of biologics because of their favorable properties. The monoclonal antibodies segment is predicted to lead the biologics market over the forecast period, primarily attributed by the increasing product demand for personalized therapies. Moreover, extensive research activities in the development of antibodies to discover various targeted therapies for a wide-range of diseases, like cancers, infections, and multiple immunological disorders.

The biologics market for oncology and auto-immune diseases is predicted to have the dominant share over the forecast period. Many small-sized and mid-sized companies are highly focusing on oncology and immunology segments, as they have high unmet medical needs, and they require higher acceptability. This primarily attributes to the growth of biologics market for oncology and auto-immune diseases segments.

Regional Analysis

The global biologics market is divided into regions that are North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America is expected to hold the largest share in the global biologics market during the forecast period. Europe and Asia Pacific are anticipated to follow North America in terms of market size. The arrival of new healthcare technologies and advancement in biomedical engineering has escalated the growth of the market in the North America region, particularly in the U.S. Chronic diseases such as cancer and auto-immune diseases are in high prevalence in this region, according to NIH. As the biologics are majorly used for the treatment of these diseases, the biologics market is predicted to have the highest share in this region. This is further attributed by the presence of large number of market players, which has further helped the growth of biologics sales in this region.

Global Biologics Market Size, Share Analysis By Region 2017

Key Players

Key market players operating in biologics market include Becton Dickinson & Company, Retractable Technologies, Inc., Bayer AG, Unilife Corporation, Smiths Medicals, Roche Diagnostics, Terumo Corporation, Novartis AG, AstraZeneca and Lundbeck.

Global Biologics Market Study Objective

1. To forecast the market size of biologics market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of biologics market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of biologics market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of biologics market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the biologics market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Global Biologics Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.